Skip to main content
Glama

Entity Profile

entity_profile
Read-onlyIdempotent

"Tell me about X" / "research Acme" / "brief me on Tesla" / "what does Apple do" / "company profile for Microsoft" / "give me the rundown on NVDA" / "everything you know about $TICKER" — full cross-source profile of a US public company in ONE parallel call. ALWAYS PREFER over chaining single-pack SEC/XBRL/news lookups when the user asks for a holistic view. Fans out across SEC EDGAR, XBRL, USPTO patents, federal contracts (USAspending), FDA-licensed biologics (Purple Book), H-1B hiring (DOL LCA), news and GLEIF, and returns: cik + company_name (+ resolved_from/resolved_to when value was a name); recent_filings (up to 5 with pipeworx://edgar/company/{cik}/filings/{accession} URIs); fundamentals (LATEST 10-K Revenues + NetIncomeLoss + Cash, sorted period_end DESC); patents (USPTO PatentsView API sunset May 2025 — soft-fails until reactivated); federal_contracts (USAspending awards where the company is the recipient); fda_products (FDA-licensed biologics — vaccines, cell/gene therapies — from the Purple Book; a company with only small-molecule/generic drugs will show none here, that is expected, not a failure); hiring (H-1B sponsorship volume + salary range from DOL LCA filings); recent news mentions via GDELT→GNews fallback; LEI via GLEIF. sources_used / sources_failed say which of these actually returned data for THIS company — an empty section is a real "no data", not a bug. Pass a ticker ("AAPL"), zero-padded CIK ("0000320193"), OR a company name ("Moderna") — names now resolve via SEC EDGAR's company-name match; a private company (no CIK/ticker) returns resolved:false with an explicit notes line, not a bare failure. type accepts "company" or "ticker" interchangeably — both take the same value shapes above.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYes"company" or "ticker" — both are accepted and behave identically; `value` can be a ticker, CIK, or company name either way. person/place coming soon.
valueYesTicker (e.g., "AAPL"), zero-padded CIK (e.g., "0000320193"), or company name (e.g., "Moderna") — names resolve via SEC EDGAR company-name match.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed3 schema fields changed
    • changedInput schema / properties / type / description
      Previous value: -"Entity type. Only \"company\" supported today; person/place coming soon."New value: +"\"company\" or \"ticker\" — both are accepted and behave identically; `value` can be a ticker, CIK, or company name either way. person/place coming soon."
    • changedInput schema / properties / type / enum
      Previous value: -[
      -  "company"
      -]New value: +[
      +  "company",
      +  "ticker"
      +]
    • changedInput schema / properties / value / description
      Previous value: -"Ticker (e.g., \"AAPL\") or zero-padded CIK (e.g., \"0000320193\"). Names not supported — use resolve_entity first if you only have a name."New value: +"Ticker (e.g., \"AAPL\"), zero-padded CIK (e.g., \"0000320193\"), or company name (e.g., \"Moderna\") — names resolve via SEC EDGAR company-name match."
  2. First observed

TDQS

A4.8/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already mark this read-only/idempotent, and the description goes much further: it discloses parallel fan-out across SEC, XBRL, USPTO, USAspending, Purple Book, DOL, GDELT/GNews, and GLEIF; explains soft-fail behavior for USPTO patents after May 2025; and clarifies that empty sections are genuine 'no data', not failures.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is long but the tool is genuinely complex, covering eight data sources and multiple output sections. It is reasonably front-loaded with the core purpose and usage preference, though some details (e.g., type interchangeability) repeat schema information and the opening example list is extensive.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

With no output schema, the description fully documents the return shape section-by-section, including source status fields, resolved_from/resolved_to, URL formats, and expected absence cases for fda_products. An agent has enough context to invoke it and interpret results correctly.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters4/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

The input schema already covers the two parameters at 100%, so the baseline is 3. The description adds value by giving concrete examples for ticker, zero-padded CIK, and company-name inputs, explaining name resolution via SEC EDGAR, and noting that type values are interchangeable.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description opens with concrete trigger phrases and then states a specific purpose: 'full cross-source profile of a US public company in ONE parallel call.' It enumerates the exact output sections (cik, recent_filings, fundamentals, patents, etc.), which clearly differentiates it from siblings like resolve_entity and compare_entities.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

It gives an explicit usage rule: 'ALWAYS PREFER over chaining single-pack SEC/XBRL/news lookups when the user asks for a holistic view.' It also specifies accepted inputs and handles the boundary case of private companies returning resolved:false with a notes line, so an agent knows when the tool does not fit.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.8/5.0
Disambiguation2/5

ask_pipeworx and ask_pipeworx_beta are explicitly described as functionally identical right now, making them near-duplicates. ai_visibility_check and scan_competitor_ai_presence also heavily overlap, and deep_research vs ask_pipeworx requires careful reading to know which to pick.

Naming Consistency4/5

Most tools follow a clear snake_case verb_noun pattern (list_templates, create_*, validate_claim). However, a few bare verbs break the pattern: compose, forget, recall, and remember.

Tool Count1/5

34 tools is already heavy, but the server is named 'Gitignore' and only 3 of 34 tools relate to .gitignore templates. The other 31 tools form a completely unrelated data platform, making the count an extreme mismatch for the apparent scope.

Completeness3/5

As a data platform, the surface is broad but has notable gaps: citations return pipeworx:// URIs yet no fetch/read-by-URI tool exists, and subscriptions support subscribe/unsubscribe/list but not update. For the gitignore name, only basic template list/get/compose is present, with the rest irrelevant to the stated purpose.